In a welcome move, MetLife stock saw its Relative Strength Rating rise from 70 to 75 on Thursday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating tracks share price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains typically have an RS Rating of over 80 in the early stages of their moves. See if MetLife stock can continue to rebound and hit that benchmark.
Looking For Winning Stocks? Try This Simple Routine
Is MetLife Stock A Buy?
MetLife stock is not currently offering a proper buying opportunity. See if the stock goes on to form a promising consolidation that could kick off a new price move.
The life insurance firm saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -25% to -5%. Revenue rose from 0% to 7%.
MetLife stock holds the No. 11 rank among its peers in the Insurance-Life industry group. Natl Western Life and Primerica are also among the group's highest-rated stocks.
